Search for:

Support Us
News and Press Releases
Events
Careers
ShareEx Login

About ICCR
Our Work
Policy/Litigation
Resources
Resolutions
Membership
Current Initiatives
Donate

Back About ICCR

About ICCR

Who We Are
How We Work

Back Our Work

Our Work

Advancing Worker Justice
Corporate Political Responsibility
- Corporate Lobbying
- Corporate Political Spending
Climate Change and Environmental Justice
Equitable Global Supply Chains
Health Equity
Digital Rights and AI Accountability
Investor Responsibility

Back Policy/Litigation

Policy/Litigation

Back Resources

Resources

ICCR’s Corporate Examiner

Back Resolutions

Resolutions

Back Membership

Membership

Member Directory
Member Benefits
Become a Member
ICCR's Legacy Award

Back Current Initiatives

Current Initiatives

Back Donate

Donate

Home » In The News » Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries

Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries

03 January 2022

Fortune

Always stay up-to-date.

Join Our Mailing List

Subscribe to ICCR's eNewsletter "The Corporate Examiner".

Name

First

Email

CAPTCHA

Δ

Interfaith Center on Corporate Responsibility

Mailing Address: 475 Riverside Drive, Suite 1842
New York, NY 10027

Address to receive checks: P.O. Box 22354
New York, NY 10087-2354

info@ICCR.org (332) 249-2212

Press Inquiries
Our Annual Report and Financial Statement
Contact Us

donate Become a member

Follow Us

Copyright 2026 EIN: 13-3235906 ICCR Nonprofit Marketing Agency by Elevation Web

Terms of Use Privacy Policy Sitemap